浏览全部资源
扫码关注微信
1.河南中医药大学中医药科学院,郑州 450046
2.河南中医药大学第一附属医院药学部,郑州 450052
Published:15 January 2023,
Received:06 July 2022,
Revised:16 November 2022,
扫 描 看 全 文
初双,吴延娆,吴丽敏等.白术乙醇提取物调节PPAR-γ信号通路促进小胶质细胞摄取及降解Aβ的作用机制研究 Δ[J].中国药房,2023,34(01):12-17.
CHU Shuang,WU Yanrao,WU Limin,et al.Study on the promotion effect mechanism of ethanol extract from Atractylodes macrocephala on microglia phagocytosis and degradation of Aβ based on regulating PPAR-γ signaling pathway[J].ZHONGGUO YAOFANG,2023,34(01):12-17.
初双,吴延娆,吴丽敏等.白术乙醇提取物调节PPAR-γ信号通路促进小胶质细胞摄取及降解Aβ的作用机制研究 Δ[J].中国药房,2023,34(01):12-17. DOI: 10.6039/j.issn.1001-0408.2023.01.03.
CHU Shuang,WU Yanrao,WU Limin,et al.Study on the promotion effect mechanism of ethanol extract from Atractylodes macrocephala on microglia phagocytosis and degradation of Aβ based on regulating PPAR-γ signaling pathway[J].ZHONGGUO YAOFANG,2023,34(01):12-17. DOI: 10.6039/j.issn.1001-0408.2023.01.03.
目的
2
基于过氧化物酶体增殖物激活受体γ(PPAR-γ)信号通路研究白术乙醇提取物(EEAM)促进小胶质细胞摄取及降解β淀粉样蛋白(Aβ)的作用机制。
方法
2
以小鼠神经小胶质细胞BV2为研究对象,采用激光共聚焦荧光显微镜观察EEAM(低、中、高剂量分别为0.3、0.4、0.5 mg/mL,下同)对细胞摄取和降解Aβ的影响;利用人胚胎肾细胞HEK293考察EEAM对PPAR-γ萤光素酶转录活性的影响;采用免疫荧光法考察EEAM对PPAR-γ核移位的影响;以Aβ
1-42
诱导阿尔茨海默病BV2细胞模型,并采用定量聚合酶链式反应法考察EEAM对PPAR-γ下游靶基因(
Lxra
、
Lxrb
、
Abca1
、
Abcg1
、
Cd36
、
Sra
和
Apoe
)mRNA表达的影响。
结果
2
Aβ摄取实验结果显示,经中、高剂量EEAM干预后,BV2细胞中Aβ荧光强度均显著升高(
P
<0.05);Aβ降解实验结果显示,经中、高剂量EEAM干预后,BV2细胞中Aβ荧光强度均显著降低(
P
<0.05)。经各剂量EEAM干预后,HEK293细胞中PPAR-γ萤光素酶转录活性均显著升高
(P
<0.05),BV2细胞中和细胞核中PPAR-γ蛋白的荧光强度(低剂量组除外)均显著升高(
P
<0.05),BV2细胞中
Lxra
、
Lxrb
、
Abca1
、
Abcg1
、
Cd36
、
Sra
、
Apoe
mRNA的表达水平均显著升高(
P
<0.05)。
结论
2
EEAM可通过激活PPAR-γ信号通路,促进小胶质细胞对Aβ的摄取与降解作用,进而改善阿尔茨海默病。
OBJECTIVE
2
To explore the effect mechanism of ethanol extract from
Atractylodes macrocephala
(EEAM) on microglial phagocytosis and degradation of amyloid β (Aβ) based on peroxisome proliferator-activated receptor γ (PPAR-γ) signaling pathway.
METHODS
2
Taking neuromicroglial cell BV2 as subjects, confocal microscopy was used to observe the effects of EEAM (0.3, 0.4, 0.5 mg/mL, similarly hereinafter) on phagocytosis and degradation of Aβ in microglia. Human embryonic kidney cell HEK293 was used to investigate the effects of EEAM on luciferase transcriptional activity of PPAR-γ. The effect of EEAM on nuclear translocation of PPAR-γ was investigated by immunofluorescence. Alzheimer’s disease BV2 cell model was induced by Aβ
1-42
, and quantitative polymerase chain reaction was used to investigate the effects of EEAM on mRNA expressions of PPAR-γ downstream target genes (
Lxra
,
Lxrb
,
Abca1
,
Abcg1
,
Cd36
,
Sra
and
Apoe
).
RESULTS
2
The results of Aβ uptake experiment showed that after the intervention of medium and high doses of EEAM, fluorescence intensity of Aβ in BV2 cells increased significantly (
P
<0.05). The degradation experiment of Aβ showed that after the intervention of medium and high doses of EEAM, fluorescence intensity of Aβ in BV2 cells decreased significantly (
P
<0.05). After the intervention of different doses of EEAM, luciferase transcriptional activity of PPAR-γ in HEK293 cells increased significantly (
P
<0.05); fluorescence intensity of PPAR-γ in BV2 cells and nuclei (except for low-dose group) increased significantly (
P
<0.05). mRNA expressions of
Lxra
,
Lxrb
,
Abca1
,
Abcg1
,
Cd36
,
Sra
and
Apoe
in BV2 cells were increased significantly (
P
<0.05).
CONCLUSIONS
2
EEAM can promote the uptake and degradation of Aβ in microglia by activating PPAR-γ signaling pathway, thus improving Alzheimer’s disease.
白术乙醇提取物过氧化物酶体增殖物激活受体γ小胶质细胞β淀粉样蛋白阿尔茨海默病
PPAR-γmicrogliaamyloid βAlzheimer’s disease
胡文军,邓朝晖,李国锋.复方脑康胶囊对β-淀粉样肽诱导SH-SY5Y细胞凋亡的保护作用研究[J].中国药房,2012,23(7):594-596.
BAKOTA L,BRANDT R. Tau biology and tau-directed therapies for Alzheimer’s disease[J]. Drugs,2016,76(3):301-313.
HANISCH U K,KETTENMANN H. Microglia:active sensor and versatile effector cells in the normal and pathologic brain[J]. Nat Neurosci,2007,10(11):1387-1394.
KUMMER M P,ISING C,KUMMER C,et al. Microglial PD-1 stimulation by astrocytic PD-L1 suppresses neuroinflammation and Alzheimer’s disease pathology[J]. Embo J,2021,40(24):e108662.
TANG Y,LE W. Differential roles of M1 and M2 micro- glia in neurodegenerative diseases[J]. Mol Neurobiol,2016,53(2):1181-1194.
KUMMER M P,SCHWARZENBERGER R,SAYAH-JEANNE S,et al. Pan-PPAR modulation effectively protects APP/PS1 mice from amyloid deposition and cognitive deficits[J]. Mol Neurobiol,2015,51(2):661-671.
XIE Z,ZHAO J,WANG H,et al. Magnolol alleviates Alzheimer’s disease-like pathology in transgenic C. elegans by promoting microglia phagocytosis and the degradation of beta-amyloid through activation of PPAR-γ[J]. Biomed Pharmacother,2020,124:109886.
易亚乔,方锐,葛金文,等.基于数据挖掘的历代医家痴呆相关病症用药规律分析[J].中国中药杂志,2018,43(16):3376-3381.
吴丽敏,王辉,王梦瑶,等.基于TrkB-CREB的白术神经保护作用机制研究[J].时珍国医国药,2021,32(10):2324-2330.
WANG P,XIE Z S,SONG J Y,et al. Four new sesquiterpene lactones from Atractylodes macrocephala and their CREB agonistic activities[J]. Fitoterapia,2020,147:104730.
吴丽敏,赵洁,张效威,等.基于LKB1-AMPK-TFEB的白术调节溶酶体自噬抗阿尔茨海默病作用机制[J].中国中药杂志,2022,47(17):4723-4732.
赵建平,吴丽敏,鲁晓娜,等.白术乙醇提取物对秀丽隐杆线虫寿命的影响及其机制研究[J].中国药房,2021,32(4):418-424.
ABGRALL A,POIZAT G,PREVOST M,et al. Evidence for the neuronal expression and secretion of adiponectin[J].Cells,2022,11(17):2725.
NAIR A K,BAIER L J. Using luciferase reporter assays to identify functional variants at disease-associated loci[J]. Methods Mol Biol,2018,1706:303-319.
ARENA T A,HARMS P D,WONG A W. High throughput transfection of HEK293 cells for transient protein production[J]. Methods Mol Biol,2018,1850:179-187.
刘志文,徐江雁,张振强,等.人参皂苷Rb1通过调节TGF-β1/Smad3信号通路抑制肾小管上皮细胞-间质转化[J].中国药房,2022,33(5):535-541.
王宁,韩晶,徐艳炜,等.过氧化氢损伤原代皮质神经元中PPAR-γ的改变[J].中华医学杂志,2015,95(21):1686-1690.
叶晓滨,孙越.益气类中药干预阿尔茨海默病作用机制的研究进展[J].中国民族民间医药,2022,31(1):78-83.
高博,张云,屈文英.黄芪甲苷Ⅳ通过激活PPAR-γ抑制NF-κB介导的炎症反应减少AD大鼠脑中淀粉样蛋白沉淀[J].脑与神经疾病杂志,2021,29(8):479-483.
SANO O,TSUJITA M,SHIMIZU Y,et al. ABCG1 and ABCG4 suppress γ-secretase activity and amyloid β production[J].PLoS One,2016,11(5):e0155400.
EDLER M K,JOHNSON C T,AHMED H S,et al. Age,sex,and regional differences in scavenger receptor CD36 in the mouse brain:potential relevance to cerebral amyloid angiopathy and Alzheimer’s disease[J]. J Comp Neurol,2021,529(9):2209-2226.
LIFSHITZ V,WEISS R,LEVY H,et al. Scavenger receptor A deficiency accelerates cerebrovascular amyloidosis in an animal model[J]. J Mol Neurosci,2013,50(1):198-203.
TICE C M,NOTO P B,FAN K Y,et al. Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core[J]. Bioorg Med Chem Lett,2016,26(20):5044-5050.
BEHL T,KAUR I,SEHGAL A,et al. The interplay of ABC transporters in Aβ translocation and cholesterol metabolism:implicating their roles in Alzheimer’s disease[J]. Mol Neurobiol,2021,58(4):1564-1582.
CAO G,BALES K R,DEMATTOS R B,et al. Liver X receptor-mediated gene regulation and cholesterol homeostasis in brain:relevance to Alzheimer’s disease therapeutics[J]. Curr Alzheimer Res,2007,4(2):179-184.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution